25 May 2026
Mapping the avoid-ome: a systematic open-science approach to predictive ADMET
Over the last 20 years, the number of new drug modalities have multiplied quickly 1 . Despite this, the oldest modality, small molecules, still accounts for ~3/4 of drugs approved by the FDA over the last decade 2 , 3 . Small molecules continue to dominate and even flourish for three main reasons: (1) small molecules have inherent distribution advantages with potential to reach every organ, cell,…
24 May 2026
A slow laser bottleneck just got a 250x AI shortcut for next-generation X-ray experiments
Building a world-class X-ray experiment begins with a laser operating at the wrong frequency. Before it becomes useful, researchers pass the beam through precision crystals twice, stepping the light from infrared into ultraviolet. That type of conversion has to be simulated before any parameter can be adjusted. Until now, that simulation was a persistent slowdown.
22 May 2026
Beyond chatbots: Why the United States is best positioned for the next phase of AI
Recently, Mind Robotics, a Palo Alto-based startup, closed a $500 million bet on machines that think and act in the physical world. It is one of dozens of signals that AI's next phase has begun. Innovation experts such as Soumitra Dutta say the US is structurally better placed than anyone to lead it.
22 May 2026
Microsoft reports are exposing AI's real cost problem: Using the tech is more expensive than paying human employees
Firms today are pushing employees to use as much AI as possible to squeeze out the technology’s productivity gains. But that pressure is leading to cracks, and those cracks may be irreparable.
22 May 2026
Inside the New Era of Healthcare Compliance: What Every Provider and Health Plan Needs to Know
Medical records used to be paperwork. Now they’re financial documents, legal documents, and increasingly, the difference between a healthy bottom line and a federal recoupment notice. Every diagnosis a clinician writes down feeds into a much larger system. Insurance reimbursement, federal payments, quality scores, and audit risk all flow from those notes. And the people reviewing them have gotten…
14 May 2026
Cerebras IPO makes billions for Benchmark but VC Eric Vishria almost didn't take the meeting
The Cerebras Systems IPO was a smash hit on Thursday, generating billions for itself, its founders, and its major investors. Among the big winners is major shareholder Benchmark, which owns 9.5% of the company. One of the firm’s general partners, Eric Vishria, has been a Cerebras board member since 2016, the year the AI chip maker was founded, having co-led its $25 million Series A round.
11 May 2026
Humanoid Robots Market to Surge from USD 2.92 Bn to USD 29.57 Bn
Humanoid Robots Market size was valued at USD 2.92 billion in 2025 and is expected to reach USD 29.57 billion by 2032, expanding at a CAGR of 39.2% during 2025-2032, according to Maximize Market Research.
09 May 2026
5 AI Jobs That Pay Over $100K and Don't Require You To Leave the House
As artificial intelligence (AI) becomes more ubiquitous, it will continue to shake up the working world as we know it. In fact, according to BCG, over the next two to three years, 50% to 55% of jobs in the U.S. will be reshaped by AI. AI jobs typically require specified experiences and skills, but if you obtain the necessary elements, you could be poised for a secure — and well-paying — career.…
08 May 2026
Next-generation probiotics: an outlook into current applications and future developments
In this Review, Kern, Tofield, Frame and Elinav discuss recent advances in the design of next-generation probiotics, from identification of candidates to therapeutic applications across diverse disease contexts, and highlight major challenges and the potential of artificial intelligence to develop effective, personalized probiotics with therapeutic functions.
